Precision Medicine

The Los Angeles-based health system is looking to build and scale personalized medicine, specialty care, hospital workflow and clinical decision support systems using artificial intelligence.

They're used to forecast the longitudinal behavior of trial participants – and by predicting individuals' likely response to a drug, can improve data quality and shorten trial timelines, says Unlearn CEO Steven Herne.

Amprion has partnered with Mayo Clinic Laboratories to expand access to its test, which detects misfolded proteins associated with Parkinson’s, Lewy body dementia, and multiple system atrophy. Russ Lebovitz, the company's CEO, explains.

Mariam AlEissa, adjunct assistant professor at Alfaisal University in Saudi Arabia, explains how genomics data can identify causes of, and help develop treatments for, non-communicable diseases.